Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study

Heather F Gidding,Gregory J Dore,Matthew G Law,Janaki Amin

doi:10.1186/1471-2458-11-52

Heather F Gidding, Gregory J Dore + Show 2 more

Open Access

https://doi.org/10.1186/1471-2458-11-52

Copy DOI

Abstract

BackgroundPrevious studies have reported an excess burden of cancer and mortality in populations with chronic hepatitis B (HBV) or C (HCV), but there are limited data comparing hospitalization rates. In this study, we compared hospitalization rates for all causes and viral liver disease in people notified with HBV or HCV in New South Wales (NSW), Australia.MethodsHBV and HCV notifications were linked to their hospital (July 2000-June 2006), HIV and death records. Standardized hospitalization ratios (SHRs) were calculated using rates for the NSW population. Random effects Poisson regression was used to examine temporal trends.ResultsThe SHR for all causes and non alcoholic liver disease was two-fold higher in the HCV cohort compared with the HBV cohort (SHRs 1.4 (95%CI: 1.4-1.4) v 0.6 (95%CI: 0.6-0.6) and 14.0 (95%CI: 12.7-15.4) v 5.4 (95%CI: 4.5-6.4), respectively), whilst the opposite was seen for primary liver cancer (SHRs 16.2 (95%CI: 13.8-19.1) v 29.1 (95%CI: 24.7-34.2)). HIV co-infection doubled the SHR except for primary liver cancer in the HCV/HIV cohort. In HBV and HCV mono-infected cohorts, all cause hospitalization rates declined and primary liver cancer rates increased, whilst rates for non alcoholic liver disease increased by 9% in the HCV cohort but decreased by 14% in the HBV cohort (P < 0.001).ConclusionHospital-related morbidity overall and for non alcoholic liver disease was considerably higher for HCV than HBV. Improved treatment of advanced HBV-related liver disease may explain why HBV liver-related morbidity declined. In contrast, HCV liver-related morbidity increased and improved treatments, especially for advanced liver disease, and higher levels of treatment uptake are required to reverse this trend.

Highlights

Previous studies have reported an excess burden of cancer and mortality in populations with chronic hepatitis B (HBV) or C (HCV), but there are limited data comparing hospitalization rates
Exclusions For the study cohorts, we examined the distribution of hospitalizations around the time of diagnosis and determined that excluding admissions before or beginning within 14 days of the hepatitis C virus (HCV) or hepatitis B virus (HBV) diagnosis was sufficient to reduce the bias towards higher rates of admission around the time of diagnosis, as previously noted [5] (n = 38 922, 15.3%)
A similar trend was seen for cases co-infected with HBV and HCV, and especially HIV, compared with mono-infected cohorts

Summary

Introduction

Previous studies have reported an excess burden of cancer and mortality in populations with chronic hepatitis B (HBV) or C (HCV), but there are limited data comparing hospitalization rates. We compared hospitalization rates for all causes and viral liver disease in people notified with HBV or HCV in New South Wales (NSW), Australia. Several data linkage studies have reported an excess burden of hepatocellular carcinoma (HCC) and mortality, from advanced liver disease [1,2,3,4,5] They highlight an increased disease burden associated with HBV/HIV, HCV/HIV and HBV/ HCV co-infection [2,3,4,6]. The aim of this study was, to compare the overall burden and trends in hospitalization rates for all causes and viral liver disease in people notified with HBV or HCV in New South Wales (NSW), Australia

Objectives

Methods

Results

Discussion

Conclusion